Position paper on the indications for the use of parathyroid hormone (PTH 1-34) in the treatment of osteoporosis

被引：1

作者：

Brown, S. L. ^{[1
]}

机构：

[1] Johannesburg Hosp, Div Endocrinol & Metab, Dept Med, Johannesburg, South Africa

来源：

JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA | 2009年 / 14卷 / 01期

关键词：

D O I：

10.1080/22201009.2009.10872192

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：61 / 62

页数：2

共 16 条

[1]

[Anonymous], 2003, PRESCR INF FORT PACK

[2]

[Anonymous], 2005, NHS GUID OST SEC PRE

[3] A Randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis [J].

Body, JJ ;

Gaich, GA ;

Scheele, WH ;

Kulkarni, PM ;

Miller, PD ;

Peretz, A ;

Dore, RK ;

Correa-Rotter, R ;

Papaioannou, A ;

Cumming, DC ;

Hodsman, AB .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (10) :4528-4535

[4]

Bone and Tooth society National Osteoporosis Society Royal College of Physicians, 2002, GLUCOCORTICOID INDUC

[5] Daily and cyclic parathyroid hormone in women receiving alendronate [J].

Cosman, F ;

Nieves, J ;

Zion, M ;

Woelfert, L ;

Luckey, M ;

Lindsay, R .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (06) :566-575

[6]

Cosman F, 2007, EFFICACY ADDING TERI

[7] Parathyroid hormone treatment for osteoporosis [J].

Cosman, Felicia .

CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2008, 15 (06) :495-501

[8] Parathyroid hormone for the treatment of osteoporosis: a systematic review [J].

Cranney, Ann ;

Papaioannou, Alexandra ;

Zytaruk, Nicole ;

Hanley, David ;

Adachi, Jonathan ;

Goltzman, David ;

Murray, Timothy ;

Hodsman, Anthony .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 175 (01) :52-59

[9] Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate [J].

Ettinger, B ;

San Martin, J ;

Crans, G ;

Pavo, I .

JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (05) :745-751

[10] Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis [J].

Hodsman, A ;

Papaioannou, A ;

Cranney, A .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 175 (01) :48-51

← 1 2 →